By creating a framework for social determinants of health that explores patients’ needs and prioritizes team members’ response, specialty practices can more effectively strengthen health equity, access to care, and health outcomes.
Social determinants of health (SDOH) have a tremendous impact on care outcomes for patients with chronic and complex disease. However, uncovering the factors that could influence outcomes—from food insecurity to health literacy to access to reliable transportation—can be challenging for specialty practices.
Researchers believe SDOH could affect 80% of health outcomes. That’s especially concerning given that recent data indicate a large proportion of adults are experiencing hardship during the COVID-19 pandemic, from economic hardship to symptoms of anxiety or depression. Adults in households with children are “more likely to report food insufficiency, symptoms of depression or anxiety, and no confidence in [their] ability to make next month’s housing payment.” Other populations that face higher risk include Black and Hispanic adults and adults 43 years and younger.
For specialty practices, the opportunity to make a significant difference in SDOH is exciting—but it can also feel intimidating. Screenings for breast cancer, colon cancer, cervical cancer, and more plunged during the pandemic. Now, experts predict a surge in patients presenting with advanced cancer, something many specialty practices already are seeing. This raises numerous practical concerns for specialty practices, including:
A systematic approach to identifying and responding to SDOH—developed as part of a chronic care management (CCM) program—can become “the great equalizer in care” by helping to address these challenges. Such an approach empowers care navigators and medical assistants to act as “extenders” for specialty care practices, making connections that uncover health risks and social needs. In doing so, it supports reliable access to care resources and community services for those who need them most.
Creating the right framework for SDOH identification and response is key. Here are 3 key elements to consider.
By creating a framework for SDOH discovery and response that explores patients’ needs and prioritizes team members’ response, specialty practices can more effectively strengthen health equity, access to care, and health outcomes in a rising-risk environment.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More